18 DHC 2026

21 - 23 January 2026
Cinical Basaal Clinical with patient perspective
Wednesday 21 January
Foyer
09:00 - 10:00
Registratie en ruimte voor werkgroep vergaderingen zaal reserveren (via dhc)
Athene B/C (Dutch spoken)
10:00 - 11:00
Educatonal SCT: nieuwe SOHO wetgeving
Moderators:
Dr. Emma de Pater,
Dr. Moniek de Witte
10:00 - 10:30
Wat zijn SOHO en wat gaat er veranderen in 2027?
Speakers:
Sanneke Matlung,
Nelleke Richters
10:30 - 11:00
Wat betekent SOHO voor stamceldonoren?
Speaker:
Mirjam Fechter
Room 14
10:00 - 11:15
Clinical Abstracts (1)
Moderator:
Dr. Alexander Leeksma
10:00 - 10:15
1334: Treatment de-escalation in good-risk DLBCL
Speaker:
Diana Al-Sarayfi
10:15 - 10:30
1346: Longitudinal ctDNA Dynamics During & After 1L Therapy in LBCL (HOVON-902)
Speaker:
Martine Chamuleau
10:30 - 10:45
1369: Cardiovascular Risk in Adults with Hematologic Malignancies: A Population Study
Speaker:
Jesse Geels
10:45 - 11:00
1404: Patient Characteristics in Adult Lymphoblastic Lymphoma: A Dutch Registry Analysis
Speaker:
Eske van Baalen
11:00 - 11:15
1399: Mucositis as driver of false-positive BDG levels in AML patients after RI chemotherapy?
Speaker:
Björn Reijnders
Room 15
10:00 - 11:00
Myeloid Abstracts (1)
Moderators:
Dr. Vincent van den Boom,
Dr. Carolien Woolthuis
10:00 - 10:15
1384: Optimizing HAMLET for Advanced RNA-Seq Diagnostics in Acute Myeloid Leukemia
Speaker:
Redmar van den Berg
10:15 - 10:30
1414: Using raw hemato-analyzer data for diagnostic improvements of hematopoietic disorders
Speaker:
Feline Spijkerboer
10:30 - 10:45
1415: Prognostic relevance of post condolidation MRD and CD34+CD38- LSC in AML
Speaker:
Kasper Croese
10:45 - 11:00
1402: Decision criteria in initiating treatment for acute myeloid leukemia in frail elderly
Speaker:
Mels Hoogendoorn
Room 4/5
10:00 - 11:00
Lymphoid Abstracts (1)
Moderators:
Drs. Teije Scholte,
Prof. dr. Annemiek van Spriel
10:00 - 10:15
1343: Increasing membrane target expression to improve immunotherapy response in B-NHL
Speaker:
Kumar Mangalam
10:15 - 10:30
1372: Hypoxia gene signature for Multiple Myeloma
Speaker:
Yilin Liu
10:30 - 10:45
1393: Driving Engineered CARgos Against Multiple Myeloma
Speaker:
Benjamin Motais
10:45 - 11:00
1433: Engineering BCMA CAR T cells for myeloma-targeted cargo delivery
Speaker:
Corine Pleijte
Room 6/7
10:00 - 11:00
Immunology Abstracts (1)
Moderators:
Dr. Marieke Griffioen,
Dr. Zsolt Sebestyen
10:00 - 10:15
1363: Immune Signatures in Older Patients with Newly Diagnosed Multiple Myeloma
Speaker:
Febe Smits
10:15 - 10:30
1389: BOB1-TCR clinical trial for B-Cell Malignancies
Speaker:
Johannes Wellershoff
10:30 - 10:45
1408: Bone marrow-derived lymphocytes: alternative source TIL therapy pediatric neuroblastoma
Speaker:
Leyma Wardak
10:45 - 11:00
1418: Engineering the next generation of γδ-TCR engineered T cell therapy: a non-viral approach
Speaker:
Dorine de Bont
Sydney
11:00 - 11:30
Pauze
Athene B/C (Dutch spoken)
11:30 - 12:30
De frontlinie van lymfoomonderzoek: pionieren met de LLPC HOVON werkgroep
Moderator:
Dr. Margot Jak
11:30 - 11:50
Deel 1
Speaker:
Dr. Marjolein van der Poel
11:50 - 12:10
Deel 2
Speaker:
Prof. dr. Marie José Kersten
12:10 - 12:30
Deel 3
Speaker:
Dr. Astrid Pulles

 

 

Room 14
11:30 - 12:30
Clinical Abstracts (2)
Moderator:
Drs. Eva Hesius
11:30 - 11:45
1335: Neurotoxicity after allogeneic stem cell transplantation
Speaker:
Pleun Schonewille
11:45 - 12:00
1368: Outcomes of PBSC vs BM in adult SCD patients undergoing haploidentical allogeneic HCT
Speaker:
Erfan Nur
12:00 - 12:15
1378: Early revaccination post allo-HSCT
Speaker:
Bridget van Put
12:15 - 12:30
1383: MIPI-RADS, uniform reporting of CT-imaging of pulmonary mould infections
Speaker:
Elizabeth de Kort
Room 15
11:30 - 12:30
Myeloid Abstracts (2)
Moderators:
Dr. Ningqing Liu,
Dr. Carlijn Voermans
11:30 - 11:45
1427: Targeting BRD9 in KMT2A-rearranged AML to circumvent MEN1 inhibitor res
Speaker:
Jenny Huang
11:45 - 12:00
1429: Unraveling subtype-specific BCOR dependencies in Acute Myeloid Leukemia
Speaker:
Alessandra De Meis
12:00 - 12:15
1434: The mutational and transcriptional landscape of pediatric KMT2Ar AML
Speaker:
Cristoforo Grasso
12:15 - 12:30
1432: Multi-omics dissection of the ZEB axis during hematopoietic differentiation
Speaker:
Aniek Martens
Room 4/5
11:30 - 12:30
Benigne Abstracts (1)
Moderator:
Drs. Amaury Monard
11:30 - 11:45
1348: Microfluidic testing in patients with Bleeding Disorder of Unknown Cause (BDUC)
Speaker:
Amaury Monard
11:45 - 12:00
1350: The Oxidantscan: Evaluating oxidant-induced RBC deformability-loss in SCD and thalassemia
Speaker:
Maryse Boesveld
12:00 - 12:15
1351: Novel deep-intronic SERPINC1 variants in families with hereditary antithrombin deficiency
Speaker:
Christian Remmelzwaal
12:15 - 12:30
1362: Plasma proteome profiling in Bleeding Disorder of Unknown Cause
Speaker:
Ina Kronevska
Room 6/7
11:30 - 12:30
Immunology Abstracts (2)
Moderators:
Dr. Caroline Rutten,
Drs. Christie Verkleij
11:30 - 11:45
1405: Engineering antibodies to target and treat AML
Speaker:
Dirk-Jan Mons
11:45 - 12:00
1357: From skull to brain: The pathophysiology of myeloproliferative neoplasm
Speaker:
Tesa Klenovšek
12:00 - 12:15
1354: Unraveling the immune-pathogenesis of aplastic anemia with imaging mass cytometry
Speaker:
Jennifer Tjon
12:15 - 12:30
1353: Novel trispecific antibody for the treatment of multiple myeloma
Speaker:
Chloe O'Neill
Sydneyzaal
12:30 - 13:30
Lunch in Sydney
Athene B/C (Dutch spoken)
13:30 - 14:30
Educational AML/MDS
Moderators:
Drs. Danielle van Lammeren,
Prof. dr. Arjan van de Loosdrecht
13:30 - 14:00
Menin remmers in AML
Speaker:
Prof. dr. Marc Raaijmakers
14:00 - 14:30
MDS: de IPSS-M in de klinische praktijk
Speaker:
Dr. Canan Alhan
Room 14
13:30 - 14:30
Clinical Abstracts (3)
Moderators:
Dr. Laurens Franssen,
Drs. Christie Verkleij
13:30 - 13:45
1377: Dynamic prediction of progression based on MRD in NDMM
Speaker:
Anna Smit
13:45 - 14:00
1386: Real-World Bispecific Antibodies in Multiple Myeloma in the Netherlands (T-REX)
Speaker:
Marjolein Appelman
14:00 - 14:15
1391: No Added Value Beyond Two Fixed Doses of Tocilizumab in CAR-T Induced CRS
Speaker:
Joost Boerman
14:15 - 14:30
1385: Zanubrutinib in rare subgroup of AL amyloidosis
Speaker:
Wouter Verhaar
Room 4/5
13:30 - 14:30
Lymphoid Abstracts (2)
Moderators:
Dr. Willem Cox,
Dr. Jeroen Guikema
13:30 - 13:45
1349: 3D CLL model recapitulates lymph node phenotypes and in vivo responses to ibrutinib
Speaker:
Marco Haselager
13:45 - 14:00
1361: CLL Genomic Profiling with Long-Read Sequencing
Speaker:
Kees van Bergen
14:00 - 14:15
1388: Convergent evolution shapes development of Burkitt lymphoma
Speaker:
Friederike Meyer-Wentrup
14:15 - 14:30
1437: A unified spatial & molecular atlas of anatomically restricted large B-cell lymphomas
Speaker:
Troy Noorderbos
Room 6/7
13:30 - 14:30
Immunology Abstracts (3)
13:30 - 13:45
1400: Impact of glycosylation on the CAR T response
Speaker:
Valerie Wiersma
13:45 - 14:00
1401: CDK4/6 degradation improves the manufacturing of CAR T cells with enhanced fitness
Speaker:
George Kladis
14:00 - 14:15
1423: Nanobody-based B7-H3 CAR T-cells for paediatric brain tumours
Speaker:
Caitlyn van de Poll
14:15 - 14:30
1409: A clinically-compatible, scalable method to generate TCR/CAR T cells from induced pluripot
Speaker:
Laura Garcia-Perez
Room 8/9 (Dutch spoken)
13:30 - 17:30
Masterclass Beenmergdiagnostiek deel 1 tot en met deel 3
13:30 - 17:30
Deel 1 van 3: Klassikale presentatie van de casus
Speakers:
Dr. Goda Choi,
Dr. Kees Meijer,
Dr. Wendy Stevens,
Dr. Marielle Wondergem
Sydney
14:30 - 15:00
Pauze
Athene B/C (Dutch spoken)
15:00 - 16:00
Harmonisatie MRD
Moderator:
Prof. dr. Arjan van de Loosdrecht
15:00 - 15:30
Belang klinische waarde MRD bij AML
Speaker:
Dr. Anna van Rhenen
15:30 - 16:00
Update ELN MRD consensus paper
Speaker:
Dr. Costa Bachas
Room 14
15:00 - 16:00
Benigne Clinical Abstracts
Moderators:
Drs. Marit Jalink,
Dr. Iris van Moort
15:00 - 15:15
1371: Quantitative protein mass spectrometry for evaluation of the coagulation protein profile
Speaker:
Britte van der Vliet
15:15 - 15:30
1413: Method-dependent variation in PT and aPTT measurements
Speaker:
Andrea van Dam
15:30 - 15:45
1332: Real-world data on screening for bleeding disorders in heavy menstrual bleeding
Speaker:
Silvia Luijten
15:45 - 16:00
1333: Thrombin generation for screening and evaluation of rare coagulation factor deficiencies
Speaker:
Bauke Haisma
Room 4/5
15:00 - 16:00
Meet the Expert

Moderator:
Dr. Vincent van den Boom

15:00 - 16:00
Gene editing
Speaker:
Dr. Emile van den Akker
Room 6/7
15:00 - 16:00
Lymphoid Abstracts (3)
Moderators:
Dr. Helga Simon Molas,
Dr. Marcel Spaargaren
15:00 - 15:15
1352: Extracellular matrix's value in testing novel CAR T cell products in Multiple Myeloma
Speaker:
Eugenia Cambiaso
15:15 - 15:30
1356: Spatial Sequencing of T-LGLL Bone Marrow
Speaker:
Mischa Vervoordeldonk
15:30 - 15:45
1411: Silmitasertib sensitizes MM to venetoclax
Speaker:
Liu Yang
15:45 - 16:00
1416: Bone marrow microenvironment-mediated resistance in multiple myeloma
Speaker:
Maaike Janssens
Room 8/9 (Dutch spoken)
15:00 - 17:30
Cursus Beenmerg diagnostiek
15:00 - 17:30
Deel 2: in groepen oplossen van de casus
Speakers:
Dr. Goda Choi,
Dr. Kees Meijer,
Dr. Wendy Stevens,
Dr. Marielle Wondergem
Sydneyzaal
16:00 - 16:30
Pauze
Athene B/C (Dutch spoken)
16:30 - 17:10
Educational Productie CAR T
Moderator:
Prof. dr. Tom van Meerten
16:30 - 17:00
Deel 1
Speaker:
dr. Bahez Gareb
16:50 - 17:10
Deel 2
Speaker:
Dr. Rosa de Groot
Room 14
16:30 - 17:30
Clinical Abstracts (4)
16:30 - 16:45
1358: Three unique psychosocial adaptation clusters characterize MPN patients
Speaker:
Annemiek Eppingbroek
16:45 - 17:00
1345: Effect of RBC transfusion on inflammatory and angiogenic pathways in patients with SCD
Speaker:
Lydian de Ligt
17:00 - 17:15
1395: The vaccinSTOP study
Speaker:
Arjen Yousefi
17:15 - 17:30
1373: Health-related quality of life during the last year of life in hematological malignancies
Speaker:
Zoë Kamperman
Room 4/5
16:30 - 17:30
Myeloid Abstracts (3)
Moderator:
Dr. Emma de Pater
16:30 - 16:45
1410: Decoding Endothelial-to-Hematopoietic Transition in hiPSC-derived Hematopoietic Organoids
Speaker:
Oyishee Ahmad
16:45 - 17:00
1428: RPS26-haploinsufficient patient-derived iPSCs exhibit impaired processing of ribosomal ...
Speaker:
Teun Slijkerman
17:00 - 17:15
1430: iPSC disease models to study and treat Diamond-Blackfan Anemia Syndrome (DBAS)
Speaker:
Chantal Clark
17:15 - 17:30
1336: MDS with isolated trisomy 19
Speaker:
Konnie Hebeda
Room 6/7
16:30 - 17:30
Meet the Expert Basaal

Moderator:

Dr. Mirjam Belderbos

16:30 - 17:30
Clonal hematopoiesis and clonal expansion:
Speaker:
Prof. dr. Gerwin Huls

Mechanisms, models and clinical implications

Room 8/9 (Dutch spoken)
16:30 - 17:30
Cursus Beenmerg diagnostiek
16:30 - 17:30
Deel 3: met docenten bespreken van de casus
Speakers:
Dr. Goda Choi,
Dr. Kees Meijer,
Dr. Wendy Stevens,
Dr. Marielle Wondergem
Dummy
17:30 - 17:45
Loop pauze
Athene B/C
17:45 - 18:30
Keynote lecture: "On the origin of cancer"

Professor dr. Ruben van Boxtel
Moderator: Dr. Mirjam Belderbos

Sydneyzaal
18:30 - 20:30
Buffet wednesday Sydneyzaal (only applicable for employees in hospitals and research institutes)
Foyer
09:00 - 10:00
Registratie en ruimte voor werkgroep vergaderingen zaal reserveren (via dhc)
Foyer 2 (Dutch spoken)
09:01 - 10:00
start verpleegkundig symposium in Foyer 2 zie apart programma
Room 14
10:00 - 11:00
Immunology Abstracts (4)
Moderator:
Drs. Joost van der Hem
10:00 - 10:15
1338: A Quantitative 3D Imaging Platform for Immune Cell Dynamics in Preclinical Models
Speaker:
Yiteng Dang
10:15 - 10:30
1337: TCRs for hematopoietic-restricted minor histocompatibility antigens
Speaker:
Georgia Koutsoumpli
10:30 - 10:45
1382: Thymus hormones modulate Graft-versus-host Disease in Pediatric HCT
Speaker:
Coco de Koning
10:45 - 11:00
1436: Donor–recipient TCR comparisons show limited αβ but persistent Vδ2⁺ γδ clonotype overlap
Speaker:
Anniek Stuut
Room 15
10:00 - 11:00
Myeloid abstracts (4)
Moderators:
Dr. Mirjam Belderbos,
Dr. Anna Marneth
10:00 - 10:15
1339: Neoantigen-specific T-cell receptors targeting recurrent mutations in AML
Speaker:
Nadine Struckman
10:15 - 10:30
1419: In silico and in vitro approaches identify SNX.2112 as a t(7;12) AML drug vulnerability...
Speaker:
Ylenia Cicirò
10:30 - 10:45
1421: Understanding relapse mechanisms post allogenic transplantation
Speaker:
Soura Mardpour
10:45 - 11:00
1435: lenalidomide response in lower risk myelodysplastic neoplasms
Speaker:
Mylene Gerritsen
Room 4/5
10:00 - 11:00
Clinical abstracts (5)
Moderator:
Dr. Aukje Kreuger
10:00 - 10:15
1347: Diagnostic value of thrombin generation in bleeding disorder of unknown cause
Speaker:
Emma Urlings
10:15 - 10:30
1359: High Prevalence of Bleeding Disorder of Unknown Cause in Women
Speaker:
Nienke Meskes
10:30 - 10:45
1365: Occurrence of venous thromboembolism in HbSC disease and sickle cell anemia and associatio
Speaker:
Nikita Azhigirov
10:45 - 11:00
1355: PERC value in diagnosing PE in SCD patients
Speaker:
Sanjay Thakoerdin
Room 6/7 (Dutch spoken)
10:00 - 11:00
Medicijnen voor patienten met Multipel Myeloom - duur?
Moderator:
Prof. dr. Sonja Zweegman

Patientenperspectief wordt meegenomen

10:00 - 10:10
Medisch bezien - Altijd waardevol?
Speakers:
Wiebe Cnossen (Hematon),
Prof. dr. Sonja Zweegman
10:10 - 10:30
Maatschappelijk bezien - Over het kostbare van kostenanalyses – alle risico daar-gelaten!
Speaker:
Dr. Hedwig Blommestein
10:30 - 10:50
Economisch bezien - Penny wise, pound foolish?
Speaker:
Prof. dr. Xander Koolman
10:50 - 11:00
Al dat bezien samengebracht - de sprekers in gesprek met elkaar en met ‘de zaal’
Room 8/9 (Dutch spoken)
10:00 - 11:00
IVIG als infectieprofylaxe: wie wanneer en wat te doen als het straks op is?
Moderator:
Drs. Elizabeth de Kort
10:00 - 10:30
Bewijs, indicaties en moeten we terughoudend zijn?
Speaker:
Dr. Anke Bruns
10:30 - 11:00
Wat is het, hoe komen we eraan en hoe komen we tot goed gebruik?
Speaker:
Dr. Cynthia So-Osman
Sydney
11:00 - 11:30
Pauze
Room 14
11:30 - 12:30
Immunology Abstracts (5)
11:30 - 11:45
1370: Advancing NK cell immunotherapy in AML
Speaker:
Janine van Elssen
11:45 - 12:00
1387: Engineering stem cell-derived NK cells with chimeric antigen receptors for immunotherapy o
Speaker:
Bart Spils
12:00 - 12:15
1390: NK cells armed with engineered anti-Her2 antibody enhance cytotoxicity in breast cancer
Speaker:
Vera Valckx
12:15 - 12:30
1403: Transfer of stem cell-derived NK cells in rel/ref AML patients: the phase 1 NK4AML study
Speaker:
Paulien van Hauten
Room 15
11:30 - 12:30
Lymphoid Abstracts (4)
Moderator:
Dr. Sara Creemers
11:30 - 11:45
1341: Less Sugar, More Target: Unlocking CD20 for Potent Antibody Killing of B-NHL
Speaker:
Willem Cox
11:45 - 12:00
1374: Enhanced ctDNA Detection in B-cell Lymphoma by using Multi-Nucleotide Variants
Speaker:
Nick Veltmaat
12:00 - 12:15
1376: WEE1 inhibitor synergizes with DNA damaging chemotherapy
Speaker:
Haiying Mo
12:15 - 12:30
1379: T-cell Kinetics during First-Line Blinatumomab Therapy in Patients with BCP-ALL
Speaker:
Rosan Olsman
Room 4/5 (Dutch spoken)
11:30 - 12:30
Meet the Expert Imaging
Moderator:
Prof. dr. Josée Zijlstra
11:30 - 12:30
Radiomics en AI bij analyse van PET-CT beelden; er is meer dan wat je ziet!   
Speaker:
Prof. dr. Ronald Boellaard
12:00 - 12:30
Multidisciplinair overleg! Casus bespreking nav de waarde van PET-gestuurde behandeling en metabool tumor volume als prognostisch kenmerk bij maligne lymfoom.
Speakers:
Dr. Anne Arens,
Dr. Julia Huijbregts
Room 6/7 (Dutch spoken)
11:30 - 12:30
Praktische uitdagingen bij de oudere CLL patient
Moderator:
Dr. Marten Nijziel
11:30 - 12:30
Casuistiek
Speakers:
Dr. Esther van Bladel,
Drs. Daan Castelijn
11:30 - 12:30
Panel leden

Prof. dr. Arnon Kater
Dr. Marianne v Maarschalkerweerd
Dr. Ilse Verpoorte

Room 8/9 (Dutch spoken)
11:30 - 12:30
Educational werkgeluk en werkdruk
11:30 - 12:00
Werkdruk en werkgeluk van de hematoloog anno 2026
Speakers:
Dr. Ellen van der Spek,
Dr. Bregje van Zaane
12:00 - 12:30
Vermindering van zorgconsumptie en afschalen controle laaggradige ziektebeelden, de Dordrecht experience
Speaker:
Dr. Peter Westerweel
Sydney
12:30 - 13:30
Lunch in Sydney
Room 11
12:31 - 13:30
Algemene Ledenvergadering JNVvH inclusief lunch in zaal 11
Athene B/C (Dutch spoken)
13:30 - 14:30
Artificial Intelligence in de spreekkamer
Moderators:
Simone van der Linden,
Dr. Jurjen Versluis

Deze sessie wordt samen georganiseerd met verpleegkundig symposium en het  patientenperspectief wordt meegenomen

13:30 - 13:50
Deel 1
13:50 - 14:10
Deel 2
14:10 - 14:30
Deel 3
Room 15
13:30 - 14:30
Lymphoid Abstracts (5)
Moderator:
Drs. Ruben Schuinder
13:30 - 13:45
1344: the role of CD59 in mediating rosette formation in Hodgkin lymphoma
Speaker:
Yajie Lei
13:45 - 14:00
1394: Hodgkin Reed-Sternberg cells actively turn monocytes into immunosuppressive macrophages
Speaker:
Rodrigo Martinez Alcala
14:00 - 14:15
1396: Multinucleation in Hodgkin Lymphoma
Speaker:
Fer de Wit
14:15 - 14:30
1412: Immunophenotypic Landscape of Peripheral T-cell lymphomas NOS
Speaker:
Lorraine Haan
Room 6/7
13:30 - 14:30
Myeloid abstracts (5)
Moderators:
Dr. Els Mansell,
Dr. Bert van der Reijden
13:30 - 13:45
1417: Tamoxifen in myeloid neoplasms
Speaker:
Luise Albuquerque-Simões
13:45 - 14:00
1422: Spatial multi-omics uncovers niche remodeling in acute myeloid leukemia
Speaker:
Merel van der Meulen
14:00 - 14:15
1424: Endogenous retroviral element expression signatures in acute myeloid leukemia subtypes
Speaker:
Anne van der Grinten
14:15 - 14:30
1426: Overcoming Monosomy 7-driven venetoclax resistance in AML cells by HDAC inhibition
Speaker:
Lara Bakker
Room 8/9 (Dutch spoken)
13:30 - 14:30
Educational Benigne
Moderator:
Dr. Ward van Beers
13:30 - 14:00
Kwaliteit van leven meten in registers voor benigne hematologie, hoe en waarom?
Speakers:
Dr. Iris Lommerse,
Dr. Martijn Oude Voshaar
14:00 - 14:30
Van zeldzame diagnose naar levensloop zorg: de patiënt met erfelijk beenmerg falen
Speaker:
Dr. Marije Bartels
Sydney
14:30 - 15:00
Pauze
Room 14
15:00 - 16:00
Myeloid abstracts (6)
Moderators:
Dr. Marije Bartels,
Dr. Micha Nethe
15:00 - 15:15
1438: Glucorticoids in hematopoiesis
Speaker:
Marije Bartels
15:15 - 15:30
1406: Rescuing chemotherapy-induced hematopoietic dysfunction
Speaker:
Tim van Tienhoven
15:30 - 15:45
1380: Idiopathic and clonal cytopenias in long-term allo-HCT survivors
Speaker:
Iris Koedijk
15:45 - 16:00
1425: Hereditary thrombocythemia caused by a calreticulin mutation
Speaker:
Julia Teders
Room 15
15:00 - 16:00
Lymphoid Abstracts (6)
Moderators:
Prof. dr. Eric Eldering,
Dr. Lisette Rozeman
15:00 - 15:20
1360: AI-Powered Fracture Risk Prediction in Multiple Myeloma
Speaker:
Djennifer Madzia-Madzou
15:15 - 15:30
1381: Uncovering EIF5A’s Role in ER-Stress Response in B cell malgiancy cell lines
Speaker:
Demi Both
15:30 - 15:45
1392: Revumenib in pediatric R/R acute leukemia
Speaker:
Maaike Luesink
15:45 - 16:00
1420: T-cell lymphoblastic lymphoma: High risk NOTCH1 gene fusions and easy to use CCL17 biom...
Speaker:
Jan Loeffen
Room 4/5
15:00 - 16:00
Clinical Abstracts (6)
Moderator:
Dr. Hans Pruijt
15:00 - 15:15
1366: Discrete choice experiment for treatment preferences in chronic lymphocytic leukemia
Speaker:
Alex Cornelisse
15:15 - 15:30
1367: Patient perspective on Watchful Waiting in CLL
Speaker:
Jantina Kortleve
15:30 - 15:45
1397: Treatment sequencing and outcomes in CLL
Speaker:
Alisa Veenstra
15:45 - 16:00
1375: Treatment Pathways in CAD/CAS; Insights from Clinical Practice
Speaker:
Taliesin Gottenbos
Room 6/7 (Dutch spoken)
15:00 - 16:00
Educational Multipel Myeloom
Moderators:
Dr. Paula Ypma,
Prof. dr. Sonja Zweegman
15:00 - 15:20
Van triple-therapie naar even niet of juist naar quadruple in de oudere patiënt met MM
Speaker:
Drs. Febe Smits
15:20 - 15:40
Een veelheid aan mogelijkheden, maar wat is de beste volgorde voor RRMM
Speaker:
Dr. Wifried Roeloffzen
15:40 - 16:00
Van studies naar de echte wereld – het brede en Nederlandse perspectief 
Speaker:
Dr. Rimke Oostvogels
Room 8/9 (Dutch spoken)
15:00 - 16:00
Educational MPN therapieën
Moderator:
Dr. Mieke Roeven
15:00 - 15:30
Erythrocytose
Speaker:
Dr. Minke Rab
15:30 - 16:00
Trombocytose
Speaker:
Dr. Peter Westerweel
Sydney
16:00 - 16:30
Pauze
Room 8/9 (Dutch spoken)
16:30 - 16:50
Beste proefschrift lecture
Room 8/9 (Dutch spoken)
16:50 - 17:15
Swammerdamprijs
Athene B/C (Dutch spoken)
17:15 - 18:00
Medisch Cabaret: Ernst van der Pasch

Moderator: dr. Suzanne van Dorp

Sydney
18:30 - 20:30
Buffet Thursday Sydneyzaal (only applicable for participants of hospital of research institutes)
Foyer
20:30 - 23:59
Sociaal Programma in Centre Court
Foyer
09:00 - 10:00
Registratie en ruimte voor werkgroep vergaderingen zaal reserveren (via dhc)
Athene B/C (Dutch spoken)
10:00 - 11:00
Grand Rounds
10:00 - 11:00
Casuistiek met expert panel
Sydneyzaal
11:00 - 11:30
Pauze
Athene B/C (Dutch spoken)
11:30 - 12:30
Thuisbehandeling anno 2026
Moderator:
Dr. Anke Janssen

Patientenperspectief wordt meegenomen

11:30 - 11:50
Patientperspectieven, thuisbehandeling op maat
Speaker:
Wiebe Cnossen (Hematon)
11:50 - 12:10
Deel 2 (titel volgt)
Speaker:
Dr. Aart Beeker
12:10 - 12:30
Intensieve AML kuren thuis; de toekomst?
Speaker:
Dr. Marielle Wondergem
Room 6/7 (Dutch spoken)
11:30 - 12:30
Educational Histio Targeted therapys
Moderator:
Dr. Suzanne van Dorp
11:30 - 12:00
Deel 1 titel volgt
Speaker:
Dr. Astrid van Halteren
12:00 - 12:30
Deel 2 titel volgt
Speaker:
dr. Sanne Tonino
Room 8/9 (Dutch spoken)
11:30 - 12:30
Symposium Vereniging Hematologisch Laboratorium
Moderator:
Prof. dr. Mathie Leers
11:30 - 11:45
Massaspectrometrie van M-Proteine: van innovatie naar implementatie
Speaker:
Dr. Erika Huijser
11:45 - 12:15
Invloed d-dimerentesten op CTLE-aanvraag en uitkomst
Speaker:
Dr. Jorn Assman
12:15 - 12:30
Update van het nieuwe difboekje VHL
Speaker:
Prof. dr. Volkher Scharnhorst
Sydneyzaal
12:30 - 13:30
Lunch in Sydney
Room 15
12:31 - 13:30
Algemene Leden Vergadering NVvH incl. lunch zaal 15
Athene B/C (Dutch spoken)
13:30 - 14:30
Het nieuwe geneesmiddel, van studie tot vergoeding
Moderator:
Dr. Mels Hoogendoorn

Patientenperspectief wordt meegenomen

13:30 - 13:50
Van data naar klinische meerwaarde, de rol van de hematoloog
Speaker:
dr. Sanne Tonino
13:50 - 14:10
Wetenschap, waardebepaling en poortwacht
Speaker:
Dr. Lonneke Timmers; Zorginstituut Nederland
14:10 - 14:30
Zorgverzekeraars en toegang tot innovatie
Speaker:
dr. Sahar van Waalwijk van Doorn-Khosrovani, CZ
Room 6/7 (Dutch spoken)
13:30 - 14:30
How to treat richtlijn primair centraal zenuwstelsel
Moderator:
Dr. Marjolein van der Poel
13:30 - 14:00
De eerste lijnsbehandeling van PCZSL, de uitdagingen
Speaker:
Dr. Jeanette Doorduijn
14:00 - 14:30
Recidief PCZSL, handen in het haar?
Speaker:
Dr. Marcel Nijland
Room 8/9 (Dutch spoken)
13:30 - 14:30
Tips en tricks transfusie geneeskunde
Moderator:
Dr. Minke Rab
13:30 - 13:50
"Waar blijft het bloed?"
Speaker:
Drs. Ayman El Idrissi
13:50 - 14:10
Help een transfusiereactie: wat nu?
Speaker:
Drs. Caroline Cantë
14:10 - 14:30
One type fits all....... of toch niet?
Speaker:
Dr. Nory Holle
Dummy
14:30 - 14:40
Korte loop pauze
Athene B/C (Dutch spoken)
14:40 - 15:45
Plenaire sessie echelonerings commissie
Register
×